MedTrace Logo

Data on the Prevention of Complications of Prophylactic Intravenous Hydration in Patients With eGFR < 30

NCT04592406 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 443

Last updated 2023-01-18

No results posted yet for this study

Summary

At Maastricht University Medical Centre (Maastricht UMC+) a specialised unit was established where a dual screening process including both renal and cardiac parameters is used to minimize the risk of contrast-induced acute kidney injury as well as the risk of prophylactic hydration in eGFR\<30mL/min/1.73m2 patients. Very little data exists on patients with eGFR \<30mL/min/1.73m2 in this context. The current study aims to describe post-contrast outcomes of patients to whom this screening method has been applied.

Conditions

  • Acute Kidney Injury (Nontraumatic)
  • Contrast-induced Nephropathy

Interventions

OTHER

CVP screening

An appropriate dual screening process including both renal and cardiac parameters to minimize the risks of post-contrast renal adverse outcomes and of prophylactic hydration in eGFR\<30mL/min/1.73m2 patients.

Sponsors & Collaborators

  • Maastricht University Medical Center

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-12-01
Primary Completion
2023-01-06
Completion
2023-01-06

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04592406 on ClinicalTrials.gov